Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q38112430)
Watch
English
Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease.
scientific article published on December 2012
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
title
Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
main subject
Alzheimer's disease
0 references
immunotherapy
1 reference
based on heuristic
inferred from title
author
Doris Lambracht-Washington
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
author name string
Roger N Rosenberg
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
publication date
1 December 2012
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
published in
Translational neuroscience
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
volume
3
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
issue
4
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
page(s)
307-313
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
exact match
https://scigraph.springernature.com/pub.10.2478/s13380-012-0037-6
0 references
cites work
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Novel Abeta immunogens: is shorter better?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Translational research on the way to effective therapy for Alzheimer disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
The current status of Alzheimer's disease genetics: what do we tell the patients?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Jump-starting the immune system: prime-boosting comes of age.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
6 September 2017
Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
14 September 2017
Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
14 September 2017
New insights into the genetics of Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
28 September 2017
Amyloid beta-protein and the genetics of Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
28 September 2017
DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
23 June 2018
Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
Safety and biomarker effects of solanezumab in patients with Alzheimer's disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
US government sets out Alzheimer's plan.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
Enhanced Th2 immunity after DNA prime-protein boost immunization with amyloid beta (1-42) plus CpG oligodeoxynucleotides in aged rats.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3670794
retrieved
31 August 2018
Alzheimer's research. Stopping Alzheimer's before it starts
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23741624
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.2478/S13380-012-0037-6
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
Dimensions Publication ID
1019392155
0 references
PMCID
3670794
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
PubMed ID
23741624
1 reference
stated in
Europe PubMed Central
PMCID
3670794
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23741624%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
ResearchGate publication ID
237061385
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
